Robert Rosenheck MD
Professor of Psychiatry and of Public Health (Health Policy)
Departments & Organizations
Drug Abuse, Addiction, and HIV Research Scholars
School of Public Health
NIMH Research Training Program in Childhood-onset Neuropsychiatric Disorders
Albert J. Solnit Integrated Training Program
Psychiatry: Mental Health Services Research, Division of
Homelessness; Post Traumatic Stress Disorder; Cost-Effectiveness Analysis more...
- M.D., University of Pennsylvania, 1973
- Rosenheck RA and Sernyak MJ. Developing a policy for second- generation antipsychotic drugs. Health Affairs 2009; 28(5): w782-w793. Published on-line July 21, 2009: http://content.healthaffairs.org/cgi/reprint/hlthaff.28.5.w782v1
- Rosenheck RA, Leslie DL, Sindelar J, Miller EA, Tariot PN, Dagerman KS, Davis S, Lebowitz BD, Rabins P, Hsiao JK, Lieberman JA, Schneider LS. Cost-Benefit Analysis of Second Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer’s Disease. Archives of General Psychiatry 2007;64(11):1259-1268.
- Rosenheck RA, Leslie D, Sindelar J, Miller EA, Lin H, Stroup S, McEvoy J, Davis S, Keefe RSE, Swartz M, Perkins D, Hsiao J, Lieberman JA. Cost-Effectiveness of Second Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia. American Journal of Psychiatry 2006; 163(12):2080-2089.